Prebiotic effects of arabinoxylan oligosaccharides on juvenile Siberian sturgeon (Acipenser baerii) with emphasis on the modulation of the gut microbiota using 454 pyrosequencing.
Identifieur interne : 000233 ( PubMed/Corpus ); précédent : 000232; suivant : 000234Prebiotic effects of arabinoxylan oligosaccharides on juvenile Siberian sturgeon (Acipenser baerii) with emphasis on the modulation of the gut microbiota using 454 pyrosequencing.
Auteurs : Zahra Geraylou ; Caroline Souffreau ; Eugene Rurangwa ; Gregory E. Maes ; Katina I. Spanier ; Christophe M. Courtin ; Jan A. Delcour ; Johan Buyse ; Frans OllevierSource :
- FEMS microbiology ecology [ 1574-6941 ] ; 2013.
English descriptors
- KwdEn :
- Animals, Bacteria (classification), Bacteria (drug effects), Bacteria (genetics), Fatty Acids, Volatile (biosynthesis), Fishes (growth & development), Fishes (metabolism), Fishes (microbiology), Gastrointestinal Tract (metabolism), Gastrointestinal Tract (microbiology), Microbiota (drug effects), Oligosaccharides (pharmacology), Prebiotics, RNA, Ribosomal, 16S (genetics), Sequence Analysis, DNA, Xylans (pharmacology).
- MESH :
- chemical , biosynthesis : Fatty Acids, Volatile.
- classification : Bacteria.
- drug effects : Bacteria, Microbiota.
- genetics : Bacteria, RNA, Ribosomal, 16S.
- growth & development : Fishes.
- metabolism : Fishes, Gastrointestinal Tract.
- microbiology : Fishes, Gastrointestinal Tract.
- chemical , pharmacology : Oligosaccharides, Xylans.
- Animals, Prebiotics, Sequence Analysis, DNA.
Abstract
The potential of a novel class of prebiotics, arabinoxylan oligosaccharides (AXOS), was investigated on growth performance and gut microbiota of juvenile Acipenser baerii. Two independent feeding trials of 10 or 12 weeks were performed with basal diets supplemented with 2% or 4% AXOS-32-0.30 (trial 1) and 2% AXOS-32-0.30 or AXOS-3-0.25 (trial 2), respectively. Growth performance was improved by feeding 2% AXOS-32-0.30 in both trials, although not significantly. Microbial community profiles were determined using 454-pyrosequencing with barcoded primers targeting the V3 region of the 16S rRNA gene. AXOS significantly affected the relative abundance of bacteria at the phylum, family, genus and species level. The consumption of 2% AXOS-32-0.30 increased the relative abundance of Eubacteriaceae, Clostridiaceae, Streptococcaceae and Lactobacillaceae, while the abundance of Bacillaceae was greater in response to 4% AXOS-32-0.30 and 2% AXOS-3-0.25. The abundance of Lactobacillus spp. and Lactococcus lactis was greater after 2% AXOS-32-0.30 intake. Redundancy analysis showed a distinct and significant clustering of the gut microbiota of individuals consuming an AXOS diet. In both trials, concentration of acetate, butyrate and total short-chain fatty acids (SCFAs) increased in fish fed 2% AXOS-32-0.30. Our data demonstrate a shift in the hindgut microbiome of fish consuming different preparation of AXOS, with potential application as prebiotics.
DOI: 10.1111/1574-6941.12169
PubMed: 23786549
Links to Exploration step
pubmed:23786549Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prebiotic effects of arabinoxylan oligosaccharides on juvenile Siberian sturgeon (Acipenser baerii) with emphasis on the modulation of the gut microbiota using 454 pyrosequencing.</title><author><name sortKey="Geraylou, Zahra" sort="Geraylou, Zahra" uniqKey="Geraylou Z" first="Zahra" last="Geraylou">Zahra Geraylou</name><affiliation><nlm:affiliation>Laboratory of Aquatic Ecology, Evolution and Conservation, KU Leuven, Leuven, Belgium; Laboratory of Livestock Physiology, Immunology and Genetics, KU Leuven, Leuven, Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Souffreau, Caroline" sort="Souffreau, Caroline" uniqKey="Souffreau C" first="Caroline" last="Souffreau">Caroline Souffreau</name></author><author><name sortKey="Rurangwa, Eugene" sort="Rurangwa, Eugene" uniqKey="Rurangwa E" first="Eugene" last="Rurangwa">Eugene Rurangwa</name></author><author><name sortKey="Maes, Gregory E" sort="Maes, Gregory E" uniqKey="Maes G" first="Gregory E" last="Maes">Gregory E. Maes</name></author><author><name sortKey="Spanier, Katina I" sort="Spanier, Katina I" uniqKey="Spanier K" first="Katina I" last="Spanier">Katina I. Spanier</name></author><author><name sortKey="Courtin, Christophe M" sort="Courtin, Christophe M" uniqKey="Courtin C" first="Christophe M" last="Courtin">Christophe M. Courtin</name></author><author><name sortKey="Delcour, Jan A" sort="Delcour, Jan A" uniqKey="Delcour J" first="Jan A" last="Delcour">Jan A. Delcour</name></author><author><name sortKey="Buyse, Johan" sort="Buyse, Johan" uniqKey="Buyse J" first="Johan" last="Buyse">Johan Buyse</name></author><author><name sortKey="Ollevier, Frans" sort="Ollevier, Frans" uniqKey="Ollevier F" first="Frans" last="Ollevier">Frans Ollevier</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23786549</idno><idno type="pmid">23786549</idno><idno type="doi">10.1111/1574-6941.12169</idno><idno type="wicri:Area/PubMed/Corpus">000233</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000233</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Prebiotic effects of arabinoxylan oligosaccharides on juvenile Siberian sturgeon (Acipenser baerii) with emphasis on the modulation of the gut microbiota using 454 pyrosequencing.</title><author><name sortKey="Geraylou, Zahra" sort="Geraylou, Zahra" uniqKey="Geraylou Z" first="Zahra" last="Geraylou">Zahra Geraylou</name><affiliation><nlm:affiliation>Laboratory of Aquatic Ecology, Evolution and Conservation, KU Leuven, Leuven, Belgium; Laboratory of Livestock Physiology, Immunology and Genetics, KU Leuven, Leuven, Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Souffreau, Caroline" sort="Souffreau, Caroline" uniqKey="Souffreau C" first="Caroline" last="Souffreau">Caroline Souffreau</name></author><author><name sortKey="Rurangwa, Eugene" sort="Rurangwa, Eugene" uniqKey="Rurangwa E" first="Eugene" last="Rurangwa">Eugene Rurangwa</name></author><author><name sortKey="Maes, Gregory E" sort="Maes, Gregory E" uniqKey="Maes G" first="Gregory E" last="Maes">Gregory E. Maes</name></author><author><name sortKey="Spanier, Katina I" sort="Spanier, Katina I" uniqKey="Spanier K" first="Katina I" last="Spanier">Katina I. Spanier</name></author><author><name sortKey="Courtin, Christophe M" sort="Courtin, Christophe M" uniqKey="Courtin C" first="Christophe M" last="Courtin">Christophe M. Courtin</name></author><author><name sortKey="Delcour, Jan A" sort="Delcour, Jan A" uniqKey="Delcour J" first="Jan A" last="Delcour">Jan A. Delcour</name></author><author><name sortKey="Buyse, Johan" sort="Buyse, Johan" uniqKey="Buyse J" first="Johan" last="Buyse">Johan Buyse</name></author><author><name sortKey="Ollevier, Frans" sort="Ollevier, Frans" uniqKey="Ollevier F" first="Frans" last="Ollevier">Frans Ollevier</name></author></analytic><series><title level="j">FEMS microbiology ecology</title><idno type="eISSN">1574-6941</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Bacteria (classification)</term><term>Bacteria (drug effects)</term><term>Bacteria (genetics)</term><term>Fatty Acids, Volatile (biosynthesis)</term><term>Fishes (growth & development)</term><term>Fishes (metabolism)</term><term>Fishes (microbiology)</term><term>Gastrointestinal Tract (metabolism)</term><term>Gastrointestinal Tract (microbiology)</term><term>Microbiota (drug effects)</term><term>Oligosaccharides (pharmacology)</term><term>Prebiotics</term><term>RNA, Ribosomal, 16S (genetics)</term><term>Sequence Analysis, DNA</term><term>Xylans (pharmacology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Fatty Acids, Volatile</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Bacteria</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Bacteria</term><term>Microbiota</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Bacteria</term><term>RNA, Ribosomal, 16S</term></keywords><keywords scheme="MESH" qualifier="growth & development" xml:lang="en"><term>Fishes</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Fishes</term><term>Gastrointestinal Tract</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Fishes</term><term>Gastrointestinal Tract</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Oligosaccharides</term><term>Xylans</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Prebiotics</term><term>Sequence Analysis, DNA</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The potential of a novel class of prebiotics, arabinoxylan oligosaccharides (AXOS), was investigated on growth performance and gut microbiota of juvenile Acipenser baerii. Two independent feeding trials of 10 or 12 weeks were performed with basal diets supplemented with 2% or 4% AXOS-32-0.30 (trial 1) and 2% AXOS-32-0.30 or AXOS-3-0.25 (trial 2), respectively. Growth performance was improved by feeding 2% AXOS-32-0.30 in both trials, although not significantly. Microbial community profiles were determined using 454-pyrosequencing with barcoded primers targeting the V3 region of the 16S rRNA gene. AXOS significantly affected the relative abundance of bacteria at the phylum, family, genus and species level. The consumption of 2% AXOS-32-0.30 increased the relative abundance of Eubacteriaceae, Clostridiaceae, Streptococcaceae and Lactobacillaceae, while the abundance of Bacillaceae was greater in response to 4% AXOS-32-0.30 and 2% AXOS-3-0.25. The abundance of Lactobacillus spp. and Lactococcus lactis was greater after 2% AXOS-32-0.30 intake. Redundancy analysis showed a distinct and significant clustering of the gut microbiota of individuals consuming an AXOS diet. In both trials, concentration of acetate, butyrate and total short-chain fatty acids (SCFAs) increased in fish fed 2% AXOS-32-0.30. Our data demonstrate a shift in the hindgut microbiome of fish consuming different preparation of AXOS, with potential application as prebiotics.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23786549</PMID><DateCreated><Year>2013</Year><Month>10</Month><Day>21</Day></DateCreated><DateCompleted><Year>2013</Year><Month>12</Month><Day>10</Day></DateCompleted><DateRevised><Year>2013</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1574-6941</ISSN><JournalIssue CitedMedium="Internet"><Volume>86</Volume><Issue>2</Issue><PubDate><Year>2013</Year><Month>Nov</Month></PubDate></JournalIssue><Title>FEMS microbiology ecology</Title><ISOAbbreviation>FEMS Microbiol. Ecol.</ISOAbbreviation></Journal><ArticleTitle>Prebiotic effects of arabinoxylan oligosaccharides on juvenile Siberian sturgeon (Acipenser baerii) with emphasis on the modulation of the gut microbiota using 454 pyrosequencing.</ArticleTitle><Pagination><MedlinePgn>357-71</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/1574-6941.12169</ELocationID><Abstract><AbstractText>The potential of a novel class of prebiotics, arabinoxylan oligosaccharides (AXOS), was investigated on growth performance and gut microbiota of juvenile Acipenser baerii. Two independent feeding trials of 10 or 12 weeks were performed with basal diets supplemented with 2% or 4% AXOS-32-0.30 (trial 1) and 2% AXOS-32-0.30 or AXOS-3-0.25 (trial 2), respectively. Growth performance was improved by feeding 2% AXOS-32-0.30 in both trials, although not significantly. Microbial community profiles were determined using 454-pyrosequencing with barcoded primers targeting the V3 region of the 16S rRNA gene. AXOS significantly affected the relative abundance of bacteria at the phylum, family, genus and species level. The consumption of 2% AXOS-32-0.30 increased the relative abundance of Eubacteriaceae, Clostridiaceae, Streptococcaceae and Lactobacillaceae, while the abundance of Bacillaceae was greater in response to 4% AXOS-32-0.30 and 2% AXOS-3-0.25. The abundance of Lactobacillus spp. and Lactococcus lactis was greater after 2% AXOS-32-0.30 intake. Redundancy analysis showed a distinct and significant clustering of the gut microbiota of individuals consuming an AXOS diet. In both trials, concentration of acetate, butyrate and total short-chain fatty acids (SCFAs) increased in fish fed 2% AXOS-32-0.30. Our data demonstrate a shift in the hindgut microbiome of fish consuming different preparation of AXOS, with potential application as prebiotics.</AbstractText><CopyrightInformation>© 2013 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Geraylou</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Laboratory of Aquatic Ecology, Evolution and Conservation, KU Leuven, Leuven, Belgium; Laboratory of Livestock Physiology, Immunology and Genetics, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souffreau</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Rurangwa</LastName><ForeName>Eugene</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Maes</LastName><ForeName>Gregory E</ForeName><Initials>GE</Initials></Author><Author ValidYN="Y"><LastName>Spanier</LastName><ForeName>Katina I</ForeName><Initials>KI</Initials></Author><Author ValidYN="Y"><LastName>Courtin</LastName><ForeName>Christophe M</ForeName><Initials>CM</Initials></Author><Author ValidYN="Y"><LastName>Delcour</LastName><ForeName>Jan A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Buyse</LastName><ForeName>Johan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Ollevier</LastName><ForeName>Frans</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>FEMS Microbiol Ecol</MedlineTA><NlmUniqueID>8901229</NlmUniqueID><ISSNLinking>0168-6496</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005232">Fatty Acids, Volatile</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009844">Oligosaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D056692">Prebiotics</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012336">RNA, Ribosomal, 16S</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014990">Xylans</NameOfSubstance></Chemical><Chemical><RegistryNumber>9040-27-1</RegistryNumber><NameOfSubstance UI="C085118">arabinoxylan</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001419" MajorTopicYN="N">Bacteria</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005232" MajorTopicYN="N">Fatty Acids, Volatile</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005399" MajorTopicYN="N">Fishes</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="N">growth & development</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D041981" MajorTopicYN="N">Gastrointestinal Tract</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="N">Microbiota</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009844" MajorTopicYN="N">Oligosaccharides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056692" MajorTopicYN="Y">Prebiotics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012336" MajorTopicYN="N">RNA, Ribosomal, 16S</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014990" MajorTopicYN="N">Xylans</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SCFA</Keyword><Keyword MajorTopicYN="N">fish</Keyword><Keyword MajorTopicYN="N">gut microbial community</Keyword><Keyword MajorTopicYN="N">nondigestible carbohydrate</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>01</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>05</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>06</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23786549</ArticleId><ArticleId IdType="doi">10.1111/1574-6941.12169</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Eau/explor/EsturgeonV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000233 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000233 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Eau
|area= EsturgeonV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:23786549
|texte= Prebiotic effects of arabinoxylan oligosaccharides on juvenile Siberian sturgeon (Acipenser baerii) with emphasis on the modulation of the gut microbiota using 454 pyrosequencing.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:23786549" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a EsturgeonV1
| This area was generated with Dilib version V0.6.27. |  |